Infection of CD34(+) hematopoietic progenitor cells by human herpesvirus 7 (HHV-7).

Abstract:

:To investigate the tropism of the T-lymphotropic human herpesvirus 7 (HHV-7) for hematopoietic progenitors, cord blood CD34(+) cells were inoculated in vitro with HHV-7 and then induced to differentiate along the granulocytic and erythroid lineages by the addition of appropriate cytokine cocktails. In semisolid assays, HHV-7 modestly affected the growth of committed (granulocytic/macrophagic and erythroid) progenitors, whereas it significantly decreased the number of pluripotent (granulocytic/erythroid/ monocytic/megakaryocytic) progenitors. Such inhibitory effect was completely abrogated by incubating HHV-7 inoculum with anti-HHV-7 neutralizing serum. In liquid cultures, HHV-7 hastened maturation along the myeloid but not the erythroid lineage, as demonstrated by the up-regulation of CD33 early myeloid antigen at day 7 of culture, and of CD15 and CD14 antigens at day 15. Moreover, HHV-7 messenger RNA was detected by reverse transcriptase-polymerase chain reaction (RT-PCR) in cells maturating along both the myeloid and the erythroid lineages. To evaluate the relevance of these in vitro findings, the presence of HHV-7 was investigated in bone marrow (BM) unfractionated mononuclear cells (MCs) as well as in purified CD34(+) and CD34(-) cell subsets, obtained from 14 normal adult donors. HHV-7 DNA was detected by DNA-PCR in 4 of 7 BMMC samples, and it was found to be associated with both the CD34(-) (2 of 7) and the CD34(+ )(1 of 7) fractions. These data indicate that HHV-7 infects BM cells in vivo and shows the ability to affect the survival/differentiation of CD34(+) hematopoietic progenitors in vitro by inhibiting more ancestral progenitors and perturbing the maturation of myeloid cells.

journal_name

Blood

journal_title

Blood

authors

Mirandola P,Secchiero P,Pierpaoli S,Visani G,Zamai L,Vitale M,Capitani S,Zauli G

subject

Has Abstract

pub_date

2000-07-01 00:00:00

pages

126-31

issue

1

eissn

0006-4971

issn

1528-0020

journal_volume

96

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells.

    abstract::Vaccination of patients with cancer using dendritic cells (DCs) was shown to be effective for B-cell lymphoma and malignant melanoma. Here we provide evidence that patients with advanced breast and ovarian cancer can be efficiently vaccinated with autologous DCs pulsed with HER-2/neu- or MUC1-derived peptides. Ten pat...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Brossart P,Wirths S,Stuhler G,Reichardt VL,Kanz L,Brugger W

    更新日期:2000-11-01 00:00:00

  • Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas.

    abstract::Primary effusion lymphoma (PEL) constitutes a subset of non-Hodgkin lymphoma whose incidence is highly increased in the context of HIV infection. Kaposi sarcoma-associated herpesvirus is the causative agent of PEL. The phosphatidylinositol 3-kinase (PI3K) signaling pathway plays a critical role in cell proliferation a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-10-251082

    authors: Bhatt AP,Bhende PM,Sin SH,Roy D,Dittmer DP,Damania B

    更新日期:2010-06-03 00:00:00

  • Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure.

    abstract::In a phase I/II study, 19 patients with advanced tumors but normal hematopoiesis and nine patients with bone marrow failure and prolonged severe cytopenias were treated with recombinant human interleukin-3 (rhIL-3) to assess the toxicity and biological effects of this multipotential hematopoietic growth factor. Doses ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ganser A,Lindemann A,Seipelt G,Ottmann OG,Herrmann F,Eder M,Frisch J,Schulz G,Mertelsmann R,Hoelzer D

    更新日期:1990-08-15 00:00:00

  • Deficient MHC class I cross-presentation of soluble antigen by murine neonatal dendritic cells.

    abstract::Neonates respond suboptimally to many vaccines. The reasons for this defect are unclear, but suboptimal antigen presentation by dendritic cells has been suggested as one possibility. In this report we describe an in vitro system that allows the generation of large numbers of resting murine neonatal dendritic cells fac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-11-3805

    authors: Kollmann TR,Way SS,Harowicz HL,Hajjar AM,Wilson CB

    更新日期:2004-06-01 00:00:00

  • How I treat lymphoma in pregnancy.

    abstract::Lymphomas afflict all age groups of people, with certain types demonstrating a female predilection in adolescents and young adults. A proportion of lymphomas that are diagnosed in this population demographic occur in the setting of pregnancy. Most of these behave aggressively at presentation and require immediate or u...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000961

    authors: Dunleavy K,McLintock C

    更新日期:2020-11-05 00:00:00

  • Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion.

    abstract::Mutations in the MYH9 gene encoding the nonmuscle myosin heavy chain IIA result in bleeding disorders characterized by a macrothrombocytopenia. To understand the role of myosin in normal platelet functions and in pathology, we generated mice with disruption of MYH9 in megakaryocytes. MYH9Delta mice displayed macrothro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-080184

    authors: Léon C,Eckly A,Hechler B,Aleil B,Freund M,Ravanat C,Jourdain M,Nonne C,Weber J,Tiedt R,Gratacap MP,Severin S,Cazenave JP,Lanza F,Skoda R,Gachet C

    更新日期:2007-11-01 00:00:00

  • Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

    abstract::Chemotherapy-related myeloid neoplasia (t-MN) is a significant late toxicity concern after cancer therapy. In the randomized intergroup phase 3 E2997 trial, initial therapy of chronic lymphocytic leukemia with fludarabine plus cyclophosphamide (FC) compared with fludarabine alone yielded higher complete and overall re...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-03-342485

    authors: Smith MR,Neuberg D,Flinn IW,Grever MR,Lazarus HM,Rowe JM,Dewald G,Bennett JM,Paietta EM,Byrd JC,Hussein MA,Appelbaum FR,Larson RA,Litzow MR,Tallman MS

    更新日期:2011-09-29 00:00:00

  • Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia.

    abstract::Richter syndrome (RS) is associated with poor outcome. The prognosis of patients with histologically aggressive chronic lymphocytic leukemia (CLL), or HAC, has not been studied. We aimed to correlate 2-deoxy-2-[(18)F]fluoroglucose/positron emission tomography (FDG/PET) data, histological diagnosis, clinical characteri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-11-536169

    authors: Falchi L,Keating MJ,Marom EM,Truong MT,Schlette EJ,Sargent RL,Trinh L,Wang X,Smith SC,Jain N,Estrov Z,O'Brien S,Wierda WG,Lerner S,Ferrajoli A

    更新日期:2014-05-01 00:00:00

  • Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.

    abstract::Administration of lymphodepletion chemotherapy followed by CD19-specific chimeric antigen receptor (CAR)-modified T cells is a remarkably effective approach to treating patients with relapsed and refractory CD19(+) B-cell malignancies. We treated 7 patients with B-cell acute lymphoblastic leukemia (B-ALL) harboring re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-08-665547

    authors: Gardner R,Wu D,Cherian S,Fang M,Hanafi LA,Finney O,Smithers H,Jensen MC,Riddell SR,Maloney DG,Turtle CJ

    更新日期:2016-05-19 00:00:00

  • Myc-Miz1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpα and Cebpδ.

    abstract::c-Myc (Myc hereafter) is found to be deregulated and/or amplified in most acute myeloid leukemias (AMLs). Almost all AML cells are dependent upon Myc for their proliferation and survival. Thus, Myc has been proposed as a critical anti-AML target. Myc has Max-mediated transactivational and Myc-interacting zinc finger p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001863

    authors: Zhang L,Li J,Xu H,Shao X,Fu L,Hou Y,Hao C,Li W,Joshi K,Wei W,Xu Y,Zhang F,Dai S,Breslin P,Zhang J,Zhang J

    更新日期:2020-04-02 00:00:00

  • Beta-arrestin 2 is required for the induction and strengthening of integrin-mediated leukocyte adhesion during CXCR2-driven extravasation.

    abstract::Leukocyte extravasation involves interdependent signaling pathways underlying the complex dynamics of firm adhesion, crawling, and diapedesis. While signal transduction by agonist-bound chemokine receptors plays a central role in the above responses, it is unclear how it contributes to the sustained and concurrent nat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-10-183699

    authors: Molteni R,Crespo CL,Feigelson S,Moser C,Fabbri M,Grabovsky V,Krombach F,Laudanna C,Alon R,Pardi R

    更新日期:2009-07-30 00:00:00

  • Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage.

    abstract::Deletion of TP53 gene, under routine assessment by fluorescence in situ hybridization analysis, connects with the worst prognosis in chronic lymphocytic leukemia (CLL). The presence of isolated TP53 mutation (without deletion) is associated with reduced survival in CLL patients. It is unclear how these abnormalities a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-07-234708

    authors: Malcikova J,Smardova J,Rocnova L,Tichy B,Kuglik P,Vranova V,Cejkova S,Svitakova M,Skuhrova Francova H,Brychtova Y,Doubek M,Brejcha M,Klabusay M,Mayer J,Pospisilova S,Trbusek M

    更新日期:2009-12-17 00:00:00

  • Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.

    abstract::The kidney is the main physiologic source of erythropoietin (EPO) in the adult and responds to decreases in tissue oxygenation with increased EPO production. Although studies in mice with liver-specific or global gene inactivation have shown that hypoxia-inducible factor 2 (Hif-2) plays a major role in the regulation ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-270322

    authors: Kapitsinou PP,Liu Q,Unger TL,Rha J,Davidoff O,Keith B,Epstein JA,Moores SL,Erickson-Miller CL,Haase VH

    更新日期:2010-10-21 00:00:00

  • Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.

    abstract::Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct subgroup of childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) that has a dismal outcome when treated with standard therapy. For improved diagnosis and risk stratification, the initiating genetic events need to be elucidated. To...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-329961

    authors: Rand V,Parker H,Russell LJ,Schwab C,Ensor H,Irving J,Jones L,Masic D,Minto L,Morrison H,Ryan S,Robinson H,Sinclair P,Moorman AV,Strefford JC,Harrison CJ

    更新日期:2011-06-23 00:00:00

  • The PI3K/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Eµ-TCL1 mouse model.

    abstract::Current treatment strategies for chronic lymphocytic leukemia (CLL) involve a combination of conventional chemotherapeutics, monoclonal antibodies, and targeted signaling inhibitors. However, CLL remains largely incurable, with drug resistance and treatment relapse a common occurrence, leading to the search for novel ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-11-610329

    authors: Blunt MD,Carter MJ,Larrayoz M,Smith LD,Aguilar-Hernandez M,Cox KL,Tipton T,Reynolds M,Murphy S,Lemm E,Dias S,Duncombe A,Strefford JC,Johnson PW,Forconi F,Stevenson FK,Packham G,Cragg MS,Steele AJ

    更新日期:2015-06-25 00:00:00

  • Conversion of platelets from a proaggregatory to a proinflammatory adhesive phenotype: role of PAF in spatially regulating neutrophil adhesion and spreading.

    abstract::The ability of platelets to provide a highly reactive surface for the recruitment of other platelets and leukocytes to sites of vascular injury is critical for hemostasis, atherothrombosis, and a variety of inflammatory diseases. The mechanisms coordinating platelet-platelet and platelet-leukocyte interactions have be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-040980

    authors: Kulkarni S,Woollard KJ,Thomas S,Oxley D,Jackson SP

    更新日期:2007-09-15 00:00:00

  • In vivo release and turnover of secreted platelet antiheparin proteins in rhesus monkey (Macaca mulatta).

    abstract::Human and rhesus monkey platelets secrete at least two antiheparin proteins: platelet factor 4 (PF4) and low affinity platelet factor 4 (LA-PF4). Neither of these proteins showed species-related antigenic differences. As determined by radioimmunoassay, the levels of PF4 and LA-PF4 antigen per 10(9) monkey platelets am...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Musial J,Niewiarowski S,Edmunds LH Jr,Addonizio VP Jr,Nicolaou KC,Colman RW

    更新日期:1980-10-01 00:00:00

  • Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features.

    abstract::All-trans retinoic acid (RA) induces complete remission in a high proportion of patients with acute promyelocytic leukemia (APL). Nevertheless, most of these patients develop RA resistance and relapse. The mechanisms of RA resistance by APL cells are still unclear. To understand the characteristics of human leukemia, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kizaki M,Matsushita H,Takayama N,Muto A,Ueno H,Awaya N,Kawai Y,Asou H,Kamada N,Ikeda Y

    更新日期:1996-09-01 00:00:00

  • A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation.

    abstract::A20 is a stress response gene in endothelial cells (ECs). A20 serves a dual cytoprotective function, protecting from tumor necrosis factor (TNF)-mediated apoptosis and inhibiting inflammation via blockade of the transcription factor nuclear factor-kappaB (NF-kappaB). In this study, we evaluated the molecular basis of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-02-0635

    authors: Daniel S,Arvelo MB,Patel VI,Longo CR,Shrikhande G,Shukri T,Mahiou J,Sun DW,Mottley C,Grey ST,Ferran C

    更新日期:2004-10-15 00:00:00

  • Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo.

    abstract::Using 2-dimensional gel electrophoresis (2D-gel) analysis, we show here that cell-cycle entry is associated with a significant increase in p27(kip1) phosphorylation in human primary B cells. A similar pattern of increase in p27(kip1) phosphorylation was also seen in 2 fast-growing tumor cell lines, Burkitt lymphoma ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2558

    authors: Zhang W,Bergamaschi D,Jin B,Lu X

    更新日期:2005-05-01 00:00:00

  • A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.

    abstract::Inherited bleeding, thrombotic, and platelet disorders (BPDs) are diseases that affect ∼300 individuals per million births. With the exception of hemophilia and von Willebrand disease patients, a molecular analysis for patients with a BPD is often unavailable. Many specialized tests are usually required to reach a put...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-12-688267

    authors: Simeoni I,Stephens JC,Hu F,Deevi SV,Megy K,Bariana TK,Lentaigne C,Schulman S,Sivapalaratnam S,Vries MJ,Westbury SK,Greene D,Papadia S,Alessi MC,Attwood AP,Ballmaier M,Baynam G,Bermejo E,Bertoli M,Bray PF,Bury L,

    更新日期:2016-06-09 00:00:00

  • Thrombopoietin initiates demethylation-based transcription of GP6 during megakaryocyte differentiation.

    abstract::Glycoprotein VI (GPVI) is an essential platelet receptor for collagens that is exclusively expressed in the megakaryocytic lineage. Transcription of the human gene GP6 is driven largely by GATA-binding protein 1 (GATA-1), specificity protein 1 (Sp1), and Friend leukemia integration 1 (Fli-1). In this report, we show t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-08-3109

    authors: Kanaji S,Kanaji T,Jacquelin B,Chang M,Nugent DJ,Komatsu N,Moroi M,Izuhara K,Kunicki TJ

    更新日期:2005-05-15 00:00:00

  • Defective homing is associated with altered Cdc42 activity in cells from patients with Fanconi anemia group A.

    abstract::Previous studies showed that Fanconi anemia (FA) murine stem cells have defective reconstitution after bone marrow (BM) transplantation. The mechanism underlying this defect is not known. Here, we report defective homing of FA patient BM progenitors transplanted into mouse models. Using cells from patients carrying mu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-03-147090

    authors: Zhang X,Shang X,Guo F,Murphy K,Kirby M,Kelly P,Reeves L,Smith FO,Williams DA,Zheng Y,Pang Q

    更新日期:2008-09-01 00:00:00

  • CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.

    abstract::Lipopolysaccharide (LPS) is a major gram-negative bacterial component that stimulates innate immune response and also induces B-lymphocyte activation. Recent studies have revealed that common molecular patterns of microorganisms such as LPS are recognized by toll-like receptors (TLRs). B cells have 2 known TLRs that m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-11-3573

    authors: Yazawa N,Fujimoto M,Sato S,Miyake K,Asano N,Nagai Y,Takeuchi O,Takeda K,Okochi H,Akira S,Tedder TF,Tamaki K

    更新日期:2003-08-15 00:00:00

  • Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma.

    abstract::Tumor-associated macrophages (TAM) are important components of the multiple myeloma (MM) microenvironment that support malignant plasma cell survival and resistance to therapy. It has been proposed that macrophages (MØ) retain the capacity to change in response to stimuli that can restore their antitumor functions. He...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-01-695395

    authors: Gutiérrez-González A,Martínez-Moreno M,Samaniego R,Arellano-Sánchez N,Salinas-Muñoz L,Relloso M,Valeri A,Martínez-López J,Corbí ÁL,Hidalgo A,García-Pardo Á,Teixidó J,Sánchez-Mateos P

    更新日期:2016-11-03 00:00:00

  • Response of hairy cells to IFN-alpha involves induction of apoptosis through autocrine TNF-alpha and protection by adhesion.

    abstract::Although hairy cell leukemia is uniquely sensitive to interferon-alpha (IFN-alpha), the biologic basis for this phenomenon remains unclear. Here we examine the effects of IFN-alpha on cultured hairy cells (HCs), taking into account the possible modifying influence of cell adhesion. We make the novel observation that t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.2.647

    authors: Baker PK,Pettitt AR,Slupsky JR,Chen HJ,Glenn MA,Zuzel M,Cawley JC

    更新日期:2002-07-15 00:00:00

  • Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation.

    abstract::To explore the use of stem/progenitor cells from peripheral blood (PB) for allogeneic transplantation, we have studied the mobilization of progenitor cells in normal donors by growth factors. Normal subjects were administered either granulocyte-macrophage colony-stimulating factor (GM-CSF) at 10 micrograms/kg/d, or G-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lane TA,Law P,Maruyama M,Young D,Burgess J,Mullen M,Mealiffe M,Terstappen LW,Hardwick A,Moubayed M

    更新日期:1995-01-01 00:00:00

  • Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.

    abstract::Treatment outcomes for older patients with acute myeloid leukemia (AML) have remained dismal. This randomized, phase 2 trial in AML patients not considered suitable for intensive induction therapy compared low-dose cytarabine (LDAC) with or without volasertib, a highly potent and selective inhibitor of polo-like kinas...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2014-03-560557

    authors: Döhner H,Lübbert M,Fiedler W,Fouillard L,Haaland A,Brandwein JM,Lepretre S,Reman O,Turlure P,Ottmann OG,Müller-Tidow C,Krämer A,Raffoux E,Döhner K,Schlenk RF,Voss F,Taube T,Fritsch H,Maertens J

    更新日期:2014-08-28 00:00:00

  • Study of the CD3-associated T-cell receptors reveals further differences between T-cell acute lymphoblastic lymphoma and leukemia.

    abstract::We show further differences between two clinically related entities, T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (T-LL), by using several monoclonal antibodies (MoAbs) reacting with either constant or variable regions of T-cell receptors (TcR) alpha beta and gamma delta or with various CD mo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gouttefangeas C,Bensussan A,Boumsell L

    更新日期:1990-02-15 00:00:00

  • Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation.

    abstract::Minimal residual disease (MRD) in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph1 ALL) who received allogeneic (n = 9) or autologous (n = 6) bone marrow transplantation (BMT) was evaluated by the polymerase chain reaction (PCR) for the bcr-abl transcript. Twelve patients received BMT a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miyamura K,Tanimoto M,Morishima Y,Horibe K,Yamamoto K,Akatsuka M,Kodera Y,Kojima S,Matsuyama K,Hirabayashi N

    更新日期:1992-03-01 00:00:00